Development of molecular targeting therapy for head and neck cancer by targeting membrane type MMP and EBV antigen

靶向膜型MMP和EBV抗原开发头颈癌分子靶向治疗

基本信息

  • 批准号:
    15390514
  • 负责人:
  • 金额:
    $ 6.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

1)Cytotoxic and cytostatic effect of Anti-MT1-MMP antibody 114F1 labeled with 131I was evaluated between HEK293 cell and MT1-MMP stable transfected-HEK293. Colony, formation assay showed there was no difference between these two cells, indicating that anti-MT1MMP with 131I did not have cytostatic effect. However, additional BB94, an inhibitor of MMP, enhanced the expression of cell surface MT1-MMP, and binding affinity of antibody to cell was enhanced 10 to 20% when 100ug of antibody was administrated.2)Affinity to MT1MMP was reevaluated among,114F,113-5B7 and AB815 using flow cytometry. It showed that AB815 had 5 to 10 fold binding affinity compared with either 114F or 113-5B7. These, results suggests that molecular targeting therapy against MT1-MMP would be improved by the use of higher affinity antibodies and MMP inhibitors.3)Epstein-Barr virus primary oncogene LMP1 locates on cell membrane. Establishment of antibody to LMP1 was first designed. However, ectodomain of LMP1 was revealed to have 6to 7 amino acids, which is insufficient to raise antibody.4)Then, the strategy was switched to look for the cell surface molecule induced by LMP1. Mucin1 was found to a specific molecule induced by LMP1 and effect, of antibody against-mucin1 should be examined in the successional experiment.
1)在HEK 293细胞和MT 1-MMP稳定转染的HEK 293之间评价131 I标记的抗MT 1-MMP抗体114 F1的细胞毒性和细胞抑制作用。集落形成实验显示两种细胞间无差异,表明抗MT 1 MMP与131 I联合作用不具有细胞抑制作用。而加入MMP抑制剂BB 94后,细胞表面MT 1-MMP的表达增强,当加入100 μ g抗体时,抗体与细胞的结合亲和力提高了10 ~ 20%。2)流式细胞术检测114 F、113- 5 B7和AB 815对MT 1-MMP的亲和力。结果表明,与114 F或113- 5 B7相比,AB 815具有5至10倍的结合亲和力。结论:3)EB病毒原癌基因LMP 1定位于细胞膜上。首先设计了抗LMP 1抗体的建立。但是,LMP 1的胞外结构域只有6 ~ 7个氨基酸,不足以产生抗体。4)随后,我们将策略转移到寻找LMP 1诱导的细胞表面分子上。Mucin 1是LMP 1诱导的特异性分子,其作用效果有待于后续实验的进一步研究。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
耳鼻咽喉科・頭頸部領域の悪性リンパ腫
耳鼻喉科/头颈部恶性淋巴瘤
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kondo S;et al.;吉崎智一;吉崎智一;吉崎智一
  • 通讯作者:
    吉崎智一
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
  • DOI:
    10.1074/jbc.m306736200
  • 发表时间:
    2003-10-17
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Endo, K;Takino, T;Sato, H
  • 通讯作者:
    Sato, H
Metastasizing mixed tumour of the parotid gland presenting as multiple lung metastases.
腮腺转移性混合瘤表现为多发性肺转移。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tonchev AB;Yamashima T;Sawamoto K;Okano H.;Yoshizaki T et al.
  • 通讯作者:
    Yoshizaki T et al.
超選択的動注化学療法-上咽頭癌-
超选择性动脉内化疗 - 鼻咽癌 -
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kondo S;et al.;吉崎智一
  • 通讯作者:
    吉崎智一
Chapter 12,Epstein-Barr virus, invasion and metastasis "Epstein-Barr virus".
第12章,Epstein-Barr病毒,侵袭和转移“Epstein-Barr病毒”。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshizaki T.;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIZAKI Tomokazu其他文献

YOSHIZAKI Tomokazu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIZAKI Tomokazu', 18)}}的其他基金

Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma
使用基于纳米聚合物的药物 NC-6004 治疗口腔鳞状细胞癌的肿瘤靶向化疗
  • 批准号:
    23659792
  • 财政年份:
    2011
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The role of intrinsic immunity for EBV-mediated nasopharyngeal carcinogenesis
内在免疫在 EBV 介导的鼻咽癌发生中的作用
  • 批准号:
    23390396
  • 财政年份:
    2011
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of nasopharyngeal carcinoma oncogenesis by Epstein-Barr virus RNA EBERs
Epstein-Barr病毒RNA EBERs导致鼻咽癌发生的分子机制
  • 批准号:
    13671775
  • 财政年份:
    2001
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了